Cardiac Monitoring & Cardiac Rhythm Management Market 2018-2025: Key Players (Abiomed, Berlin Heart GmbH, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Koninklijke Philips N.V., Cardiac Science Corporation)

Industry Trend Analysis
The cardiac monitoring & cardiac rhythm management market is expected to be worth 32.44billion by 2025, while growing at a CAGR of 4.12%. The market is largely driven by factors such as rising incidence of cardiovascular disorders along with technological advancements in cardiac monitoring & cardiac rhythm management devices. According to a report published by American Heart Association in 2017, around 92.1 million American adults are living with some or other type of cardiovascular disease. The estimated number of new heart attacks in U.S. is 580,000 with 210,000 incidences of recurrent attacks.Moreover, increasing geriatric population around the world also contributes substantially to the market growth as older adults are more susceptible to cardiovascular disorders such as stroke, heart failure, congenital heart disease, angina, arrhythmia and myocardial infarction. However, high cost of devices, inadequate insurance coverage and more preference for drugs is expected to slow down growth of the cardiac monitoring and rhythm management market.

Product Outlook and Trend Analysis
The electrocardiogram (ECG) devices segment held the major share of the cardiac monitoring devices market in 2016 owing to their critical benefits in detecting cardiac infarction, coronary vessel diseases, lack or abundance of certain minerals and their influence on impulse conduction and atrial fibrillation or atrial flutter. Event monitors segment is expected to grow with the fastest growth rate during the forecast period owing to their small size and light weight which makes them convenient to be carried to the patient’s site. The defibrillators segment is expected to hold the largest share of the cardiac rhythm management market during the forecast period owing to large scale adoption of defibrillators around the world along with rising incidence of sudden heart attacks (SCA).

Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-CMR-HnM-55018

End User Outlook and Trend Analysis
Hospitals and clinics segment accounted for the majority share of the overall market in 2016 due to the large scale adoption of cardiac monitoring & cardiac rhythm management devices in hospital settings to treat patients suffering from acute and chronic cardiovascular diseases. Ambulatory surgical centers segment is expected to witness fastest growth during the forecast period due to the advent of advanced devices which enable cost effective cardiac monitoring and management as compared to hospital based treatment.

Regional Outlook and Trend Analysis
North America held a major share of the cardiac monitoring & cardiac rhythm management market in 2016 owing to rising incidence of heart failure and arrhythmia accompanied by increasing geriatric population. Also, availability of favorable reimbursement policies related to cardiac monitoring & cardiac rhythm management devices in the region is expected to largely contribute to the robust growth of North American market. Asia-Pacific cardiac monitoring & cardiac rhythm management market is expected to exhibit fastest growth over the forecast period due to the presence of highly unmet medical needs in the region along with increasing disposable income of the population in the region.

Competitive Insights
The major players operating in the global cardiac monitoring & cardiac rhythm management market emphasize on product development in order to introduce advanced products in accordance with the changing needs and demands of the market. For instance, in May 2017, Abbott Laboratories announced the CE Mark and first use of its new Confirm Rx Insertable Cardiac Monitor (ICM). It is the world’s first ICM that is compatible with a smartphone which will help physicians in detecting cardiac arrhythmias including atrial fibrillation.

Some of the key players operating in the cardiac monitoring & cardiac rhythm management market are, Abiomed, Berlin Heart GmbH, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Koninklijke Philips N.V., Cardiac Science Corporation, General Electric Company, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, ReliantHeart Inc., Schiller AG and St. Jude Medical, LLC.

Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-CMR-HnM-55018

Market Opportunities
The key opportunity for the players operating in cardiac monitoring & cardiac rhythm management market lies in the development of technologically advanced products which deliver enhanced value to the patients suffering from cardiovascular diseases. Also, miniaturization of products has been a growing trend in the market which largely improves the convenience of use of cardiac monitoring and rhythm management devices. With increasing disposable income in the emerging markets with prevalence of unmet medical needs, market players can largely benefit by expanding distribution to such markets and secure competitive advantage.

Cardiac Monitoring & Cardiac Rhythm Management Market Segmentation:

By Product:
Cardiac Monitoring Devices
Electrocardiogram (ECG) Devices
ECG Devices, By Type
Stress ECG
Resting ECG
Holter Monitors
ECG Devices, By Lead Type
Single Lead
12 Lead
3-6 Lead

Cardiac Output Monitoring
Noninvasive COM
Minimally Invasive COM
Implantable Loop Recorder
Event Monitors
Event Monitors, By Type
Pre-symptom
Post-symptom
Event Monitors, By Technology
Autodetect Monitors
Manual Event Monitors
Cardiac Rhythm Management Devices
Pacemakers
Implantable Pacemakers
External Pacemakers
Defibrillators
Implantable Cardioverter Defibrillators (ICDs)
Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
Dual-chamber ICDs
Single-chamber ICDs
Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)
External Defibrillator
Manual External Defibrillator
Automated External Defibrillator (AEDs)
Semi-automated External Defibrillator
Fully Automated External Defibrillator
Wearable Cardioverter Defibrillator (WCDs)
Cardiac Resynchronization Therapy (CRT) Devices
CRT-P (CRT with Pacemaker Function)
CRT-D (CRT with Pacemaker and ICD Function)
Ventricular Assist Devices (VADs)
Right Ventricular Assist Device (RVAD)
Left Ventricular Assist Device (LVAD)
Biventricular Assist Device (BIVAD)

By End User:
Hospitals & Clinics
Home Settings
Ambulatory Surgical Centers (ASCs)

Enquiry for Customization@ https://www.qurateresearch.com/report/customize/HnM/QBI-CMR-HnM-55018

About Us:
Qurate Business Intelligence delivers unique market research solutions to its customers and help them to get equipped with refined information and market insights derived from reports. We are committed to providing best business services and easy processes to get the same. Qurate Business Intelligence considers themselves as strategic partners of their customers and always shows the keen level of interest to deliver quality.

Runwal Platinum,
Ramnagar Colony, Bavdhan,
Pune, Maharashtra, India-411021
https://www.qurateresearch.com/
IN +919881074592
info@qurateresearch.com

This release was published on openPR.